Brandes International Equity C holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Brandes International Equity Fund Class C BIECX
- NAV / 1-Day Return 28.54 / −0.31 %
- Total Assets 2.7B
-
Adj. Expense Ratio
1.790%
- Expense Ratio 1.710%
- Distribution Fee Level Below Average
- Share Class Type Level Load
- Category Foreign Large Value
- Investment Style Large Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 2.10%
- Turnover 30%
USD | NAV as of Jul 21, 2026 | 1-Day Return as of Jul 21, 2026, 12:11 AM GMT+0
Morningstar’s Analysis BIECX
Will BIECX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Sanofi SA | 3.09 | 82M | Healthcare |
Northern Institutional Treasury Premier | 2.81 | 74M | Cash and Equivalents |
SAP SE | 2.56 | 68M | Technology |
Alibaba Group Holding Ltd Ordinary Shares | 2.36 | 62M | Consumer Cyclical |
Takeda Pharmaceutical Co Ltd | 2.35 | 62M | Healthcare |
Henkel AG & Co KGaA | 2.25 | 60M | Consumer Defensive |
Wal - Mart de Mexico SAB de CV | 2.23 | 59M | Consumer Defensive |
Heineken Holding NV | 1.98 | 52M | Consumer Defensive |
The Swatch Group AG | 1.95 | 52M | Consumer Cyclical |
Reckitt Benckiser Group PLC | 1.89 | 50M | Consumer Defensive |